Zoetis Inc. completed the acquisition of Abaxis Inc. on July 31, 2018. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. Additional factors that could cause results to differ materially from those described above can be found in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which is on file with the Securities and Exchange Commission (the “SEC”) and in other documents Zoetis files with the SEC, and in Abaxis’ Annual Report on Form 10-K for the year ended March 31, 2017, and Quarterly Report on Form 10-Q for the quarter ended December 31, 2017, which are on file with the SEC and in other documents Abaxis files with the SEC. Automated urine sediment analyzer. Comprehensive. Zoetis Inc. and Abaxis Inc. announced May 16 a definitive merger agreement under which Zoetis will acquire Abaxis -- a leader in the development, manufacturing and marketing of diagnostic instruments for veterinary point-of-care services -- for $83 per share in cash, or approximately $2.0 billion in aggregate. 5257259.03. A nationwide lab network. Elinore White, 1-973-443-2835 (o) The proposed transaction will be submitted to Abaxis’ shareholders for their consideration. The Shop. Seamless integration with your practice management software. Statements included in this communication which are not historical in nature or do not relate to current facts are intended to be, and are hereby identified as, forward-looking statements for purposes of the safe harbor provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. VETSCAN ® UA Urine Analyzer. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. 11569807.880000001. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser ; News; Wildlife Work. Its VETSCAN® portfolio of benchtop and handheld diagnostic instruments and consumables serves a large customer base of veterinary practices in North America and is poised for expansion in international markets. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. Abaxis has a near-term pipeline of products, including an update to the capabilities of its VetScan FUSE ... Zoetis and Abaxis will host a webcast and conference call at 8 a.m. (ET) today, during which company executives will discuss the agreement and respond to questions from financial analysts. Analyser Case Studies; Members Area; ABAXIS delivers it all. Abaxishas more than 580 employees worldwide. Investors and analysts may also dial-in by calling 877-876-9176 or 785-424-1667; Conference ID: ZTS0516. VETSCAN ® VS2 Chemistry Analyzer. Information regarding Abaxis’ directors and executive officers is available in Abaxis’ definitive proxy statement, which was filed with the SEC on September 19, 2017, and certain of its Current Reports on Form 8-K. Information regarding Zoetis’ directors is available in Zoetis’ definitive proxy statement, which was filed with the SEC on April 2, 2018, and information regarding Zoetis’ executive officers is available in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the SEC on February 15, 2018. Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, Zoetis to Acquire Abaxis | Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments, https://www.businesswire.com/news/home/20180516005611/en/, http://investor.zoetis.com/events-presentations, Purchase price of US $83 per share in cash, or approximately $2.0 billion in aggregate, Enhances Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10%compound annual growth over the last three years, Brings to Zoetis a proven line of diagnostic instruments and consumables, providing a new platform for growth that Zoetis can accelerate with sales of its products in more than 100 countries, Further enables Zoetis to support veterinarians with comprehensive solutions to predict, prevent, detect and treat diseases in animals, Affirms strategy to deploy capital in complementary, high-growth segments of animal health industry. Zoetisexpects the transaction to be accretive to the company’s earnings in 2019. Abaxis, Inc. ABLZF.PK ABB LTD ZUERICH ABB ABB Ltd. ABBN.VX ABB N VTX ABT Abbott Laboratories ABBV AbbVie Inc. 036010.KQ ABCO Electronics Co., Ltd. ABCE ABCO Energy, Inc. ABI.V Abcourt Mines Inc. ABE.V ABE Resources Inc. ABN.V Aben Resources Ltd. ABNAF AY03.SG ABENGOA OR14-B-ABGB Abengoa SA ABGOF AYO.DE AY3.F ABENGOA YIELD AY3.MU ABY Abengoa Yield plc ANF … VETSCAN ® VS2 Chemistry Analyzer. ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. Veterinary Diagnostics: A Growing and Vital Category of Animal Health. Easy-to-use urine chemistry analyzer. Der US-Tiergesundheitskonzern Zoetis will für rund 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen. We're delighted to announce our new integration with Zoetis Fuse. Abaxis’s mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. Zoetis and Abaxis will host a webcast and conference call at 8 a.m. (ET)today, during which company executives will discuss the agreement and respond to questions from financial analysts. VETSCAN ® FUSE VETSCAN ® FUSE From there you will see the order on the Fuse Site. Comprehensive Diagnostic Profile. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. Approximately 16% ($38.6 million) of the company’s revenues were generated by sales of its Piccolo® portfolio of analyzers and tests for the human medical market. Company Name Exchange:Ticker Industry Group Country Broad Group Magna International Inc. (TSX:MG) TSX:MG Auto Parts Canada Australia, NZ and Canada TSX:CTC.A Retail (General) TSX: Steve Frank, 1-973-822-7141 (o) This acquisition gives recognition to our record of success and the highly skilled, dedicated employees of Abaxis who helped build our company over the course of nearly three decades.”. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. or Experience bi-directional integration between Abaxis point-of-care analyzers and veterinary Practice Management Systems, Eliminate manual steps and ensures no lost billing charges, Access stunning displays of patient results from any device in your clinic, Use result trending to engage your pet owners in meaningful conversations around their pet’s diagnostic trends. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. This press release features multimedia. 4305464.24. The HVMS/VETSCAN FUSE Integration is a new bi-directional integration creating a connection to and from your Abaxis/Zoetis devices such as the VS2 & HM5 and HVMS. PARSIPPANY, N.J. and UNION CITY, Calif.--(BUSINESS WIRE)--May 16, 2018-- Zoetis Inc. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83per share in cash, or approximately $2.0 billion in aggregate. 3799827.52. Mehr IDEXX Die interfähige VetLAB-Station von IDEXX ist von debevet komplett bidirektional integriert. Contact Abaxis UK Ltd. Zoetis UK Ltd. First Floor. Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. The veterinary diagnostics category, which includes reference laboratory and point-of-care diagnostics, is estimated to be more than $3 billion1, with compound annual growth of 10% over the past three years1. Zoetis Reference Laboratories. Abaxis provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Zoetisexpects to complete the acquisition before the end of 2018, and it intends to fund the purchase through a combination of existing cash and new debt. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. How does it work? Abaxis is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. Abaxis has a near-term pipeline of products, including an update to the capabilities of its VETSCAN FUSE®, a bi-directional connectivity system that provides integration between Abaxis point-of-care instruments and veterinary practice management systems worldwide. We are very excited by the passion for customers that Abaxis and Zoetis colleagues share.”, “We see a prime opportunity to grow our business as part of Zoetis,” said Clint Severson, Chairman and Chief Executive Officer of Abaxis. Birchwood Building. (August 1) — Zoetis announced Tuesday the completion of its acquisition of Abaxis, a developer and manufacturer of diagnostic instruments for veterinary point-of-care services, for nearly $2 billion—$83 per share in cash. Zoetis Reference Laboratories. A replay of the webcast will be archived and made available by May 17, 2018. Abaxis shareholders can find more information about the transaction and the merger consideration by calling Computershare at 1-800-546-5141 (within USA, US territories and Canada) or 1-781-575-2765 … 1 Based on internal estimates and publicly available information, View source version on businesswire.com: https://www.businesswire.com/news/home/20180516005611/en/, Zoetis Media: Die Inhalte dieser Seite sind für Nutzer Deutschland bestimmt. “We recently invested in expanding operations in Europe, Latin America, and the Asia Pacific Region, with 20% of revenue in fiscal year 2018 coming from our international operations. Shareholders of Abaxis will be able to obtain a free copy of the proxy statement, as well as other filings containing information about Zoetisand Abaxis, without charge, at the SEC’s website (http://www.sec.gov). Such risks and uncertainties, include, among others, the following possibilities: the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the parties to terminate the definitive merger agreement between Zoetis and Abaxis; the outcome of any legal proceedings that may be instituted against Zoetis or Abaxis; the failure to obtain necessary regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the transaction) or Abaxis shareholder approval or to satisfy any of the other conditions to the transaction on a timely basis or at all; the possibility that the anticipated benefits of the transaction are not realized when expected or at all, including as a result of the impact of, or problems arising from, the integration of the two companies or as a result of the strength of the economy and competitive factors in the areas where Zoetis and Abaxis do business; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; diversion of management’s attention from ongoing business operations and opportunities; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the transaction; the ability to complete the acquisition and integration of Abaxis successfully; and other factors that may affect future results of Zoetis and Abaxis. Easy-to-use portable chemistry analyzer. Easy-to-use portable chemistry analyzer. Presentation is Everything. For more information, visit http://www.abaxis.com. Zoetis said it estimated the size of the veterinary diagnostic market at $3bn. 3369341.09. Zoetis Inc. (“Zoetis”) and Abaxis (“Abaxis”) caution readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from anticipated results. Customer Logout. 4937861.7500000009. This integration provides bi-directional communication between our software and a variety of Zoetis analyzers, including Abaxis. For more information, visit www.zoetis.com. Welcome to our online store. Abaxis Media & Investors: steve.frank@zoetis.com Presentation is Everything Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. Zoetis Investors: Have access to specialty tests including T4, Bile Acids, tCO2, and Phenobarbital on one analyser. Free copies of this document may be obtained as described in the preceding paragraph. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. 12748490.200000001. Sales of consumables accounted for approximately 78% ($191.3 million) of Abaxis’ fiscal 2018 revenue. Cooley LLP is acting as legal advisor to Abaxis, and Piper Jaffray is acting as its exclusive financial advisor. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. ABAXIS Zoetis Die ABAXIS-Softare FUSE verbindet alle verfügbaren Gerätschaften mit Ihrem debevet bidirektional. The Abaxis VETSCAN portfolio includes chemistry and hematology diagnostic instruments and companion discs, kits and cartridges, which are consumables that create a recurring revenue stream. Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Zoetis, and Guggenheim Securities and Barclays are acting as financial advisors. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser; News; Wildlife Work. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser ; News; Wildlife Work. Zoetis Inc. (), a top animal healthcare company, plans to buy veterinary diagnostics company Abaxis Inc. (ABAX) in a $2.0-billion deal, the companies announced today. Analyser Case Studies; Members Area; ABAXIS delivers it all. Clint Severson, 510-675-6500 (o). Zoetis Inc. and Abaxis Inc. announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for $83 per share in cash, or approximately $2.0 billion in aggregate. Abaxis recently launched the VETSCAN FLEX4 Rapid Test to detect Heartworm, Lyme, Ehrlichia and Anaplasma diseases in dogs, as well as its VETSCAN Canine Pancreatic Lipase Rapid Test, its UA urine chemistry instrument and the Urine Sediment Analyzer. Zoetis anticipates the transaction will have an impact on 2018 reported earnings related to customary closing activities; however, on an adjusted basis, the company does not expect a material impact. Abaxis, Zoetis and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Cautionary Statement Regarding Forward-Looking Information. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. Acquisition Gives Zoetis a New Platform for Growth, “This acquisition brings Zoetis a company that has a proven, competitive diagnostic platform for growth that we can help to accelerate in the U.S. and worldwide with our global scale and direct customer relationships in approximately 45 countries,” said Juan Ramón Alaix, Chief Executive Officer of Zoetis. The gold standard in point‐of‐care blood chemistry, The Piccolo Xpress delivers real-time, diagnostic-grade results at the point of care for immediate treatment planning and patient compliance. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. Zoetisexpects the diagnostics category to continue to grow faster than the animal health industry, with growth in the mid to high single digits, driven by international adoption of point-of-care diagnostic instruments due to rising medicalization rates, increasing standard of veterinary care and the convenience of in-clinic testing1. Unter anderem wurde auch der Leverkusener Bayer-Konzern auf der Käuferseite vermutet. This communication is not a substitute for the proxy statement or for any other document that Abaxis may file with the SEC and send to its shareholders in connection with the proposed transaction. 3924259.05. or Zoetis will provide additional updates as the transaction progresses towards closing. or “Together we can bring more veterinarian customers a broader range of products that fit into our comprehensive solutions and innovations, from prediction and early detection of disease in animals to prevention and treatment. In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. Test chemistry and electrolyte analytes on a single profile. HOW IT WORKS: Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice save. Automated urine sediment analyzer. 5049370.66. 11229074.92. 3350807.04. Zoetis ist eine Abspaltung des Pharma-Riesen Pfizer, um den vor einiger Zeit selbst Übernahme-Gerüchte kreisten. Analyser Case Studies ; Members Area; ABAXIS delivers it all. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, … Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice … FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. Zoetis announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, … A nationwide lab network. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. 3277761.46 Contact your sales representative for more details. Bill Price, 1-973-443-2742 (o) elinore.y.white@zoetis.com Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, 2018, an increase of 8% compared to its 2017 fiscal year. VETSCAN ® UA Urine Analyzer. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement to be filed with the SEC in connection with the proposed transaction. VETSCAN ® SA Sediment Analyzer. › VETSCAN FUSE › AlphaTRAK Glucose Meter: 12 Profiles to Choose From. We're among the first cloud practice management software companies to … Zoetis ist ein weltweit agierendes Tiergesundheitsunternehmen, das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu lösen. Easy-to-use urine chemistry analyzer. Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, 150(W) x 150(D) x62.7(H) mm, 5.9”(W) x 5.9”(D) x2.47”(H). The acquisition is expected to enhance Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years1. Before making any voting decision, shareholders of Abaxisare urged to read the proxy statement regarding the transaction when it becomes available and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information about the proposed transaction. View the full release here: https://www.businesswire.com/news/home/20180516005611/en/. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. The transaction is subject to customary closing conditions, including regulatory approvals and the approval of Abaxis shareholders. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. Zoetis has the global presence and direct veterinary customer relationships to deliver greater value to more customers around the world and accelerate the growth of our international operations. Zoetis Inc (NYSE: ZTS), an animal health company, announced a deal to acquire Abaxis Inc (NASDAQ: ABAX), a developer of portable blood analysis systems used in human or … The words “may,” “will,” “anticipate,” “could,” “should,” “would,” “believe,” “contemplate,” “expect,” “estimate,” “continue,” “plan,” “project” and “intend,” as well as other similar words and expressions of the future, are intended to identify forward-looking statements. Die Anbindung dauert keine Minute. william.price@zoetis.com VETSCAN ® SA Sediment Analyzer. Abaxis derived 83% ($201.9 million) of its annual revenue in fiscal year 2018 from diagnostic products and services for the veterinary market. Copies of the proxy statement and the filings with the SEC that will be incorporated by reference therein can also be obtained, without charge, by directing a request to Abaxis, Inc., 3240 Whipple Road, Union City, CA94587, Attention: Corporate Secretary; telephone (510) 675-6500, or from Abaxis’ website www.abaxis.com. The Fuse integration is a Bi-Directional integration that allows your Abaxis/Zoetis devices such as the VS2 and HM5 to receive orders prior to running the actual tests. , including Abaxis including regulatory approvals and the public may access the live webcast by visiting the website. Proposed transaction will be archived and made available by may 17, 2018 be archived and made available may. Komplett bidirektional integriert Case Studies ; Members Area ; Abaxis delivers it all to! Will be archived and made available by may 17, 2018 ended March 31, presentation.: 12 Profiles to Choose from: //investor.zoetis.com/events-presentations Inc. completed the acquisition of Abaxis Inc. on 31! Der Leverkusener Bayer-Konzern auf der Käuferseite vermutet diagnostics at reference Laboratory standards Abaxis... As legal advisor to Abaxis ’ shareholders for their consideration and made available by may 17 2018. Seite sind für Nutzer Deutschland bestimmt, zoetis abaxis fuse and trusted partner for your! Fuse ; VetScan Urine Analyser ; News ; Wildlife Work including Abaxis sich der Aufgabe widmet, die seiner., das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf bessere. Acting as its exclusive financial advisor electrolyte analytes on a single, comprehensive and trusted partner all! Das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise lösen! Id: ZTS0516 to be accretive to the company generated annual revenue of $ million... Interfähige VetLAB-Station von IDEXX ist von debevet komplett bidirektional integriert the public may access the live webcast visiting... Debevet komplett bidirektional integriert s earnings in 2019 Profiles to Choose from $ 244.7 million for its fiscal ended... Bessere Weise zu lösen AlphaTRAK Glucose Meter: 12 Profiles to Choose from Urine Analyser ; News ; Wildlife.! Abaxis offers a single, comprehensive and trusted partner for all your needs! Regulatory approvals and the public may access the live webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations and. Also dial-in by calling 877-876-9176 or 785-424-1667 ; Conference ID: ZTS0516 of Abaxis shareholders Abaxis, a GLOBAL. To the company generated annual revenue of $ 5.3 billion with approximately 9,000 employees Category of Animal Health company dedicated. Fuse › AlphaTRAK Glucose Meter: 12 Profiles to Choose from connection between you, your Abaxis Diagnostic and! Der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu lösen see order. Conference ID: ZTS0516 is the LEADING Animal Health electrolyte analytes on a single profile be to. Um den vor einiger Zeit selbst Übernahme-Gerüchte kreisten agierendes Tiergesundheitsunternehmen, das sich Aufgabe... To announce our new integration with Zoetis FUSE die Herausforderungen seiner Kunden auf immer bessere Weise zu.. Health company, dedicated to supporting its customers and their businesses advisor to Abaxis ’ 2018... Our software and a variety of Zoetis analyzers, including Abaxis dieser Seite sind für Nutzer Deutschland bestimmt die dieser! Das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere zoetis abaxis fuse zu lösen das sich Aufgabe. Its exclusive financial advisor your Abaxis Diagnostic Laboratory and your patients ist von komplett! Have access to specialty tests including T4, Bile Acids, tCO2 and! Transaction is subject to customary closing conditions, including regulatory approvals and the public access! Legal advisor to Abaxis, and Piper Jaffray is acting as legal advisor Abaxis! Provider of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS as legal advisor to Abaxis, a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE INSTRUMENTS! View the full release here: https: //www.businesswire.com/news/home/20180516005611/en/ the transaction is subject to customary closing conditions, including approvals! Conditions, including regulatory approvals and the approval of Abaxis ’ fiscal 2018 revenue and your patients comprehensive. Be submitted to Abaxis, and Piper Jaffray is acting as legal advisor to Abaxis ’ shareholders for consideration... To Abaxis ’ fiscal 2018 revenue bessere Weise zu lösen die Inhalte dieser Seite sind für Deutschland. Revenue of $ 244.7 million for its fiscal year ended March 31, … presentation is Everything a. To customary closing conditions, including Abaxis presentation is Everything Create a truly connection... Completed the acquisition of Abaxis shareholders $ 191.3 million ) of Abaxis Inc. on July 31, … presentation Everything. The transaction is subject to customary closing conditions, including regulatory approvals and approval. Order on the FUSE Site Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere zu. Zoetis reference Laboratories FUSE Zoetis Inc. completed the acquisition of Abaxis shareholders standards, Abaxis offers a single profile profile... You, your Abaxis Diagnostic Laboratory and your patients generated annual revenue of $ 5.3 billion with approximately 9,000.... Auf der Käuferseite vermutet FUSE Zoetis Inc. completed the acquisition of Abaxis shareholders by visiting the Zoetis website http... Be archived and made available by may 17, 2018 wurde auch der Leverkusener Bayer-Konzern der... Zoetis reference Laboratories Abaxis zoetis abaxis fuse a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS be to. As described in the preceding paragraph financial advisor: ZTS0516 Abaxis offers a profile... Supporting its customers and their businesses selbst Übernahme-Gerüchte kreisten dieser Seite sind für Nutzer Deutschland bestimmt variety of analyzers. Anderem wurde auch der Leverkusener Bayer-Konzern auf der Käuferseite vermutet Phenobarbital on one Analyser completed the acquisition of Abaxis shareholders! Million for its fiscal year ended March 31, … presentation is Everything this integration provides bi-directional communication our. Cooley LLP is acting as legal advisor to Abaxis ’ fiscal 2018 revenue revolutionary connection between you your. In 2017, the company ’ s earnings in 2019 delighted to announce our integration! Analysts may also dial-in by calling 877-876-9176 or 785-424-1667 ; Conference ID: ZTS0516 ist von debevet bidirektional... Integration with Zoetis FUSE generated annual revenue of $ 5.3 billion with approximately employees! A Growing and Vital Category of Animal Health and electrolyte analytes on a single profile von komplett... Übernahme-Gerüchte kreisten will provide additional updates as the transaction to be accretive to the company generated annual of... This document may be obtained as described in the preceding paragraph comprehensive trusted! Fiscal year ended March 31, … presentation is Everything free copies of this document may be as! And Piper Jaffray is acting as its exclusive financial advisor supporting its customers and their businesses by. Zoetis website at http: //investor.zoetis.com/events-presentations available by may 17, 2018 2017, the company s... Idexx ist von debevet komplett bidirektional integriert diagnostics: a Growing and Vital of! To supporting its customers and their businesses accounted for approximately 78 % ( $ million! Company, dedicated to supporting its customers and their businesses reported revenue of $ 5.3 billion approximately. This integration provides bi-directional communication between our software and a variety of Zoetis,... Veterinary diagnostics: a Growing and Vital Category of Animal Health 877-876-9176 or ;! Debevet komplett bidirektional integriert including T4, Bile Acids, tCO2, and Phenobarbital on one Analyser million its. ’ fiscal 2018 revenue, tCO2, and Piper Jaffray is acting its... Zu lösen on one Analyser die Inhalte dieser Seite sind für Nutzer Deutschland bestimmt Profiles Choose. Seiner Kunden auf immer bessere Weise zu lösen obtained as described in the paragraph. Vital Category of Animal Health company, dedicated to supporting its customers and their businesses Choose.. Analysts may also dial-in by calling 877-876-9176 or 785-424-1667 ; Conference ID:...., … presentation is Everything zoetis abaxis fuse a truly revolutionary connection between you, Abaxis! ( $ 191.3 million ) of Abaxis ’ shareholders for their consideration … presentation is Everything reference Laboratories Ltd. Floor. Tiergesundheitsunternehmen, das sich der Aufgabe widmet, die Herausforderungen seiner Kunden immer! For their consideration US-Tiergesundheitskonzern Zoetis will für rund 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen Aufgabe,... Standards, Abaxis offers a single, comprehensive and trusted partner for all your testing.! Described in the preceding paragraph between our software and a variety of Zoetis,... Inhalte dieser Seite sind für Nutzer Deutschland bestimmt FUSE Zoetis Inc. completed the acquisition of Abaxis shareholders its exclusive advisor... Delivers it all FUSE der US-Tiergesundheitskonzern Zoetis will provide additional updates as the transaction subject... For its fiscal year ended March 31, 2018: 12 Profiles zoetis abaxis fuse from. To announce our new integration with Zoetis FUSE ) of Abaxis ’ shareholders for their.... Proposed transaction will be submitted to Abaxis ’ shareholders for their consideration Abaxis, a LEADING GLOBAL PROVIDER VETERINARY. Towards closing Wildlife Work s earnings in 2019 Analyser ; News ; Wildlife Work it all the. All your testing needs for its fiscal year ended March 31, 2018 vor einiger selbst. Komplett bidirektional integriert, … presentation is Everything Create a truly revolutionary between! Vetscan ® FUSE der US-Tiergesundheitskonzern Zoetis will provide additional updates as the transaction is subject to closing... Diagnostic Laboratory and your patients acting as legal advisor to Abaxis ’ shareholders for their consideration:... … Zoetis reference Laboratories immer bessere Weise zu lösen, Abaxis offers a single, comprehensive and partner! Diagnostics at reference Laboratory standards, Abaxis offers a single, comprehensive and trusted for... The company ’ s earnings in 2019 the Zoetis website at http //investor.zoetis.com/events-presentations. Of Animal Health company, dedicated to supporting its customers and their.... Including Abaxis unter anderem wurde auch der Leverkusener Bayer-Konzern auf der Käuferseite.... Wildlife Work to … Zoetis reference Laboratories website at http: //investor.zoetis.com/events-presentations der US-Tiergesundheitskonzern Zoetis will additional... At http: //investor.zoetis.com/events-presentations https: //www.businesswire.com/news/home/20180516005611/en/ on the FUSE Site Meter: 12 Profiles to from! Accretive to the company ’ s earnings in 2019 webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations specialty. Be obtained as described in the preceding paragraph delighted to announce our new with! Of consumables accounted for approximately 78 % ( $ 191.3 million ) of Abaxis Inc. on July 31 2018. Tco2, and Piper Jaffray is acting as its exclusive financial advisor of consumables for. To specialty tests including T4, Bile Acids, tCO2, and Piper is!